Slingsby Partners recommended in the IAM Patent 1000 2024

Slingsby Partners LLP is pleased to announce that we have been recommended in the IAM Patent 1000 2024 for UK patent prosecution. The IAM Patent 1000 2024 has the following to say about the firm:

“An impressive firm that is a trusted partner for high-quality drafting and prosecution services”, Slingsby Partners can be relied on to get results. “The team are highly knowledgeable and well versed in their clients’ technologies as well as their business goals, and offer great support and astute advice to help these goals become a reality. They always pitch legal advice at the right level, whether presenting to legal counsel, the CEO or external investors, providing the perfect amount of detail in a step-by-step, digestible manner, while remaining pragmatic and business focused.” Firm namesake Philip Slingsby “has a really strong command of the business realities which his clients are facing and uses this to provide the best possible advice”. He is a dynamic and collaboratively minded practitioner who brings together an immensely strong squad to service patrons across diverse and multifaceted sectors. He works alongside Rosalind Fenwick and Nick Wright to draft and prosecute applications on behalf of medical equipment manufacturer CMR Surgical, which has developed a groundbreaking surgical robot. Fenwick “deftly handles all aspects of prosecution work. Her biggest asset is her excellent management and organisation skills – she always ensures her clients are aware of deadlines, nothing is ever missed and the communication is exceptional”. Wright is a tech-savvy practitioner with a talent for identifying the kernel of inventions and translating tricky concepts into clear, well-designed patent applications. “Paul Roberts forms a deep understanding of the technical fields his client works in and drafts comprehensive applications that capture inventions in their entirety. His work is consistently done to an exceptional standard, particularly when working in the field of electronics.” Wright and Roberts team up with Stephen Turner to help Imagination Technologies maximise its IP protection, through drafting and filing a significant number of patent applications. Turner takes the lead prosecuting Imagination Technologies’ patents covering its core technologies at the USPTO; he understands the commercial significance of robust patent protection and how to effectively monetise inventions. “Tony Smee handles all stages of European prosecution and is distinguished in the market through the ownership he takes over each matter and his ability to consistently add value. He does not simply act as a middleman to pass along information from foreign offices; he is proactive in his approach to helping clientele find paths forward, even in difficult situations.” “David King is a skilled patent drafter and prosecutor who clearly explains each step of the process to his clients. Any potential problem he identifies is always served alongside numerous potential solutions.” IAM Patent 1000 newcomer Kathy Lumsden is “very knowledgeable and detail oriented; her advice is easy to understand, pragmatic and commercially relevant”. She is particularly skilled when handling chemical, pharmaceutical and mechanical inventions, and stands out for her advocacy skill at the EPO.

https://www.iam-media.com/rankings/patent-1000/profile/firm/slingsby-partners-llp 

News & insights

Slingsby Partners included in the FT's list of Europe’s Leading Patent Law Firms 2024

We are delighted to be named, once again, as one of Europe’s Leading Patent Law Firms 2024 by the Financial Times.

Read more

Slingsby Partners recommended in the IAM Patent 1000 2024

Slingsby Partners LLP is pleased to announce that we have been recommended in the IAM Patent 1000 2024 for UK patent prosecution. The IAM Patent 1000 2024 has the following to say about the firm:

Read more

New Referral to the Enlarged Board of Appeal (EBA) expected concerning the approach to claim interpretation

The long running saga of if, how and when the description can or should be used to interpret the claims of an EP patent may well be coming to a close.

Read more